These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30647122)

  • 21. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
    Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of ARL4C inhibits osteogenic differentiation of human adipose-derived stem cells through disruption of the Wnt signaling pathway.
    Wang W; Wang S; Liu X; Gu R; Zhu Y; Zhang P; Liu Y; Zhou Y
    Biochem Biophys Res Commun; 2018 Feb; 497(1):256-263. PubMed ID: 29432742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
    Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
    Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADP-ribosylation factor-like 4C binding to filamin-A modulates filopodium formation and cell migration.
    Chiang TS; Wu HF; Lee FS
    Mol Biol Cell; 2017 Nov; 28(22):3013-3028. PubMed ID: 28855378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.
    Kim Y; Jo M; Schmidt J; Luo X; Prakash TP; Zhou T; Klein S; Xiao X; Post N; Yin Z; MacLeod AR
    Mol Ther; 2019 Sep; 27(9):1547-1557. PubMed ID: 31303442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
    J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
    Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
    J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancer.
    Zhang J; Zhang Q; Sun C; Huang Y; Zhang J; Wang Q
    Biomed Pharmacother; 2020 May; 125():110000. PubMed ID: 32070877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors.
    Lobos-González L; Silva V; Araya M; Restovic F; Echenique J; Oliveira-Cruz L; Fitzpatrick C; Briones M; Villegas J; Villota C; Vidaurre S; Borgna V; Socias M; Valenzuela S; Lopez C; Socias T; Varas M; Díaz J; Burzio LO; Burzio VA
    Oncotarget; 2016 Sep; 7(36):58331-58350. PubMed ID: 27507060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth.
    Ma WK; Voss DM; Scharner J; Costa ASH; Lin KT; Jeon HY; Wilkinson JE; Jackson M; Rigo F; Bennett CF; Krainer AR
    Cancer Res; 2022 Mar; 82(5):900-915. PubMed ID: 34921016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H.
    Lin Q; Peng S; Yang Y
    Int J Oncol; 2018 Jul; 53(1):266-274. PubMed ID: 29749468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
    Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M
    Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells.
    Witort E; Lulli M; Carloni V; Capaccioli S
    J Chemother; 2013 Oct; 25(5):292-7. PubMed ID: 24070137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.